Abstract:Importance: Research is beginning to elucidate the sophisticated mechanisms underlying the microbiota-gut-brain-immune interface, moving from primarily animal models to human studies. Findings support the dynamic relationships between the gut microbiota as an ecosystem (microbiome) within an ecosystem (host) and its intersection with the host immune and nervous systems. Adding this to the effects on epigenetic regulation of gene expression further complicates and strengthens the response. At the heart is inflammation, which manifests in a variety of pathologies including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis (MS). Observations: Generally, the research to date is limited and has focused on bacteria, likely due to the simplicity and cost-effectiveness of 16s rRNA sequencing, despite its lower resolution and inability to determine functional ability/alterations. However, this omits all other microbiota including fungi, viruses, and phages, which are emerging as key members of the human microbiome. Much of the research has been done in pre-clinical models and/or in small human studies in more developed parts of the world. The relationships observed are promising but cannot be considered reliable or generalizable at this time. Specifically, causal relationships cannot be determined currently. More research has been done in Alzheimer's disease, followed by Parkinson's disease, and then little in MS. The data for MS is encouraging despite this. Conclusions and relevance: While the research is still nascent, the microbiota-gut-brain-immune interface may be a missing link, which has hampered our progress on understanding, let alone preventing, managing, or putting into remission neurodegenerative diseases. Relationships must first be established in humans, as animal models have been shown to poorly translate to complex human physiology and environments, especially when investigating the human gut microbiome and its relationships where animal models are often overly simplistic. Only then can robust research be conducted in humans and using mechanistic model systems.

Microbiota and Neurological Disorders: A Gut Feeling

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

The gut microbiome in neurological disorders

Gut Microbes and Neuropathology: Is There a Causal Nexus?

Gut microbiota: a new insight into neurological diseases

Targeting Gut Microbiota Dysbiosis: Potential Intervention Strategies for Neurological Disorders

Neuromicrobiology Comes of Age: The Multifaceted Interactions between the Microbiome and the Nervous System

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Gut Microbiota Interaction with the Central Nervous System throughout Life

Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?

Dysbiosis: Gut feeling

Interactions between the microbiota and enteric nervous system during gut-brain disorders

Gastrointestinal Dysfunction in Neurological and Neurodegenerative Disorders

The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders

The Microbiota–Gut–Brain Axis and Neurological Disorders: A Comprehensive Review

The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases

The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature

Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application

Microbiome and Brain: Gut Microbiota and Neuroendocrine System

The Microbiota-Gut-Brain Axis.